StonvexLoading…
StonvexStonvexStonvexCore line items from PLAB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-10-31 | Annual 2024 2024-10-31 | Annual 2023 2023-10-31 | Annual 2022 2022-10-31 |
|---|---|---|---|---|
Revenue | $849.29M | $866.95M | $892.08M | $824.55M |
Operating Income | $208.16M | $221.52M | $253.05M | $211.87M |
Net Income | $136.41M | $130.69M | $125.48M | $118.79M |
EPS (Diluted) | $2.28 | $2.09 | $2.03 | $1.94 |
Total Assets | $1.80B | $1.71B | $1.53B | $1.32B |
Total Liabilities | $207.23M | $231.30M | $250.61M | $253.74M |
Cash & Equivalents | $492.26M | $598.49M | $499.29M | $319.68M |
Free Cash Flow OCF − CapEx | $59.66M | $130.50M | $170.88M | $162.85M |
Shares Outstanding | 57.63M | 61.95M | 61.31M | 60.79M |